Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developments in viral hepatitis.

A J Zuckerman

    Journal of Medical Virology
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Viral hepatitis, including types A, B, and non-A non-B, is a global health concern. Research intensified with the discovery of Australia antigen, a marker for hepatitis B virus infection.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Selected Sumaries.

    Acta clinica Belgica·2016
    Same author

    Viral hepatitis and haemophilia: an introduction.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Trials of Live Influenza Vaccine in the Royal Air Force.

    British medical journal·2010
    Same author

    ABO Blood Groups and Acute Respiratory Virus Disease.

    British medical journal·2010
    Same author

    Acute hepatitis.

    British medical journal·2010
    Same author

    Coe (Coxsackie A 21) virus, para-influenza virus and other respiratory virus infections in the R.A.F., 1958-60.

    The Journal of hygiene·2010
    Same journal

    Delineating RSV-A and RSV-B: Epidemiological Patterns, Diagnostics, Clinical Severity, and Preventive Approaches.

    Journal of medical virology·2026
    Same journal

    Assessment of Residual-Serum SARS-CoV-2-N-Antigen Testing for Hospital Surveillance in Germany.

    Journal of medical virology·2026
    Same journal

    JQKD82 Inhibits HIV Infection of Macrophages Through Blocking Viral Entry and Enhancing Antiviral ISG Responses.

    Journal of medical virology·2026
    Same journal

    Commentary on "Broadly Protective Antibody-Like Vaccines Against Highly Pathogenic Coronaviruses".

    Journal of medical virology·2026
    Same journal

    Torque Teno Virus Dynamics in Plasma and BAL of COVID-19 ARDS Patients With and Without ECMO.

    Journal of medical virology·2026
    Same journal

    Comprehensive Evaluation of the Elecsys HCV Duo Immunoassay for Active Hepatitis C Detection: Insights From the DEPCDUO Study.

    Journal of medical virology·2026
    See all related articles

    Area of Science:

    • Hepatology
    • Virology
    • Public Health

    Background:

    • Viral hepatitis represents a significant global public health challenge.
    • Endemic occurrence of viral hepatitis worldwide necessitates ongoing research.
    • Hepatitis virus types A, B, and the 'non-A non-B' category are key areas of study.

    Purpose of the Study:

    • To provide an overview of viral hepatitis as a public health issue.
    • To highlight the different types of viral hepatitis.
    • To discuss the significance of the Australia antigen discovery in hepatitis B research.

    Main Methods:

    • Literature review on viral hepatitis epidemiology and virology.
    • Analysis of clinical and pathological similarities among hepatitis types.
    • Focus on the discovery and implications of the Australia antigen.

    Related Experiment Videos

    Main Results:

    • Viral hepatitis is widespread and poses a major health burden globally.
    • Hepatitis A, B, and non-A non-B represent distinct but related viral infections.
    • The Australia antigen serves as a crucial marker for hepatitis B virus infection.

    Conclusions:

    • Understanding the different types of viral hepatitis is critical for public health strategies.
    • The identification of specific viral markers, like Australia antigen, advances diagnostic and research capabilities.
    • Continued investigation into viral hepatitis is essential for disease control and prevention.